Personalised Medicine News
A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.
Published: Dec 20, 2016 9:29:15 AM
Many pain-sensing nerves in the body are thought to respond to all types of ‘painful events’, but new UCL research in mice reveals that in fact most are specialised to respond to specific types such as heat, cold or mechanical pain.
Published: Nov 14, 2016 11:14:30 AM
The risk of developing a psychotic disorder such as schizophrenia is highest for young people, men, ethnic minorities and people living in urban areas and poorer neighbourhoods, finds a new study by UCL and the University of Cambridge.
Published: Oct 24, 2016 5:24:25 PM
Human Papillomavirus (HPV) drives a greater number of head and neck cancers than previously thought, finds new research from UCL and the University of Southampton.
Published: Oct 6, 2016 4:15:32 PM
A new spin-out company Achilles Therapeutics has been launched to develop immunotherapies for cancer, based on the work of scientists from UCL and its associated hospitals.
Published: Oct 5, 2016 4:43:56 PM
UCL’s three biomedical research centres (BRCs) have won more
than £167 million in funding from the National Institute for Health Research
(NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more
funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively.
Published: Sep 14, 2016 2:58:18 PM
The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs. Next to St Pancras station and the British Library, the Crick will be the biggest biomedical research institute under one roof in Europe.
Published: Sep 1, 2016 10:32:32 AM
An international study involving UCL has made advances in understanding the ways in which genetic risk factors alter gene function in schizophrenia.
Published: Aug 30, 2016 3:34:22 PM
Researchers at UCL and Queen’s University Belfast have discovered that a drug originally developed to treat cardiovascular disease has the potential to reduce diabetes related blindness.
Published: Jun 14, 2016 1:02:15 PM
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London.
Published: Jun 10, 2016 4:18:28 PM
Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust.
Published: Apr 22, 2016 9:36:29 AM
Universities and Science Minister Jo Johnson has sought to reassure researchers that the proposed restrictions preventing the use of government grants to ‘lobby’ government will not apply to funding from the Research Councils, HEFCE or the National Academies.
Published: Apr 21, 2016 10:20:47 AM
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice led by UCL, Memorial Sloan Kettering (MSK) Cancer Center in New York and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona.
Published: Mar 31, 2016 12:48:52 PM
A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center.
Published: Mar 24, 2016 9:19:13 AM
The reason why the body’s immune cells cause so much damage and can’t regulate themselves in patients with lupus has been revealed in a UCL study published in the journal Immunity, a finding which could lead to more effective ways of treating lupus.
Published: Mar 9, 2016 5:15:35 PM